Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
Universal screening of women with gynecologic malignancies for early palliative care decreased the use of aggressive measures at the end of life.
Diagnosis & Disease Information
Endometrial Cancer Survivors in High-Poverty Areas Have Impaired Access to Self-Care Resources
Living in a high-poverty region is associated with lower access to obesity-related self-care resources.
Priority Symptoms Identified in Recurrent Ovarian Cancer
There are 18 core priority symptoms that should be routinely assessed in patients with recurrent ovarian cancer to provide higher quality of care.
Web-based Symptom Management Improves Symptom Controllability in Ovarian Cancer
Nurse-guided and self-directed web-based symptom management interventions (WRITE Symptoms) improved symptom controllability among women with recurrent ovarian cancer.
Comorbidities May Predict Non-Home Discharge After Hysterectomy
Presence of 1 risk factor or 2 or more risk factors is associated with non-home discharge after hysterectomy for gynecologic malignancy.
Some Quality Metrics Inconsistent With Long-Term Clinical Outcomes Goals
Study finds that instituting a health system-wide quality metric, such as postoperative hospital readmission rate, may be inconsistent with long-term clinical outcomes goals.
Perioperative Pain Control Reduces Need for Postoperative Narcotics After Hysterectomy for Uterine Cancer
Preoperative intravenous acetaminophen plus local infiltration of LB during hysterectomy and surgical staging of uterine cancer may reduce the need for postoperative narcotics.
Chemotherapy or VBT Improve Survival in Uterine Papillary Serous Carcinoma
Use of chemotherapy or vaginal brachytherapy (VBT) may improve survival among patients with early-stage uterine papillary serous carcinoma.
Perioperative Celecoxib Reduces Outpatient Narcotic Use After Hysterectomy
Perioperative celecoxib use during hysterectomy may reduce the need for oral narcotics after hospital discharge.
High Rates of Persistent Opioid Use 6 Months After RT for Cervical Cancer
Nearly 3 in 10 cervical cancer survivors were still using opioids at 6 months after completing radiotherapy.
- Loading...
Loading...
Next post in SGO 2017 Annual Meeting
Loading... 
Loading...